A novel therapy of haploidentical transplantation combined with umbilical cord blood unit provides s

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户:cjw37600
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
HLA-mismatched/haploidentical transplantation for high-risk hematologic malignancies is associated with the increased risk of severe aGVHD,and poor overall survival (OS).We conducted a haploidentical transplantation combined with a third party single umbilical cord blood (UCB),known as co-transplantation.
其他文献
Background:Peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)constitutes a heterogeneous group of T-cell malignancy.Resistant to conventional chemotherapy,patients usually have poor disease
会议
Background Central nervous system (CNS) relapse would seriously impair the prognosis of the patients with diffuse large B-cell lymphoma (DLBCL).However the risk factors of CNS relapse remain unclear,e
会议
Purpose MMSET (WHSC1/NSD2) is a SET domain-containing histone H3K36 methyltransferase.Its expression is deregulated in a subgroup of multiple myelomas (MM) with the t(4;14)(p16;q32)translocation assoc
会议
Introduction Hemophagocytic lymphohistiocytosis (HLH),also known as hemophagocytic syndrome (HPS) is characterized by cytokines storm and uncontrolled activation of macrophages.Secondary HLH in adults
会议
Background Changes in lipoproteins levels in sickle cell disease (SCD) patients are well-known,but the physiological ramifications of the low levels observed have not been entirely resolved.Aim The ai
会议
Objective Whether paroxysmal nocturnal hemoglobinuria clones in aplastic anemia is a prognostic factor to immunosuppressive therapy is a subject of debate.The aim of this study was to evaluate the hem
会议
Background The Non-Hodgkin lymphomas (NHL) comprise a heterogeneous group of malignancies.NHL includes both B-cell and T-cell malignancies.High dose chemotherapy followed by autologous stem cell trans
会议
Introduction Mobilisation of hematopoietic peripheral blood stem cell (PBSC) represent a standard procedure in patients prior to an autologous stem cell transplant.Starting 2008,the biosimilars GCSF w
会议
Introduction Oral fludarabine was introduced in the United States in 2003 for the treatment of patients with hematologic malignancies as an alternative to its intravenous(i.v.) formulation,introduced
会议
Background Transplantation of cells,tissues,and organs has been recognized by the World Health Organization (WHO) as an important medical task for its member states.
会议